Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-019950-42Phase 3Active
Phase 3, randomised trial in Malaria comparing Riamet arm with Malarone arm (2 arms). Primary endpoint: Need for second treatment before day 28. Started Apr 2010; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-019950-42.